Acambis plc has won FDA approval for its smallpox vaccine ACAM 2000, the first new biodefense vaccine to be licensed since the U.S. government launched Project Bioshield in 2001. (BioWorld International)
Following its recent failure to obtain accelerated approval from the FDA for its prostate cancer drug satraplatin, GPC Biotech AG has responded by cutting 46 positions at its Princeton, N.J., site, which represents approximately 15 percent of its payroll. (BioWorld International)
RSS